Latest Press Release Biohpp

7/25/2019 Latest Press Release Biohpp

1/3

bredent GmbH & Co.KGWeissenhorner Strasse 2 | 89250 Senden | Germany | Telephone +49 (0) 7309/872-22 | Fax +49 (0) 7309/872-24 |[email protected] | www.bredent.com

bredent medical GmbH & Co.KGWeissenhorner Strasse 2 | 89250 Senden | Germany | Telephone +49 (0) 7309/872-600 | Fax +49 (0) 7309/872-635 |[email protected] | www.bredent-medical.com

LATEST PRESS RELEASE

from bredent GmbH & Co. KG

Senden, 28 March 2013

BioHPP A new material class in dental prosthetic

Photo: Harald Schwindt, Landau

High-performance polymers belong to the future in dentistry too. You therefore increasingly find

perfect dental implant prosthetic solutions through new, innovative materials and technologies. With its

competency in plastics, bredent will display concepts around BioHPPat the IDS 2013.

BioHPPis a material developed to meet the requirements of dental prosthetics, whose predecessors

are being used successfully in human medicine for more than 30 years as spinal intermediate bodies,

knuckle joints and hip joint prosthetics, so that their bio-compatibility and mechanical properties are

already tried and tested. These high-performance polymers have high long-term stability and low

water retention.

Thanks to the white colour "White Shade and its physiological elasticity in the area of bones, BioHPP

is particularly good as framework material for small and big high-value fittings. The remarkable

strength, the optimum polish and the low affinity to plaque formation are very impressive.

bredent offers two different options of processing:


2/3



- BioHPPas milling blank with special cutter for the manufacture of prosthetic fittings in the

common CAD/CAM processes.

- Processing of BioHPPby means of a pressing procedure, through the for2 press

system, a specially developed vacuum pressing device.

The wide visio.lign range of pre-fabricated or customized veneering materials are available for the

veneering ofBioHPP, which is bonded to the BioHPPwith the help of a special primer having the

highest possible shear resistance.

Another very interesting indication is the manufacture of individual abutments with the help of the over-

pressing technology in the for 2 press system. Here, the abutment is modelled and finally over-

pressed individually according to the shape of the tooth on the SKY elegance Titanium base. Ahomogeneous bonding takes place between the Titanium base and BioHPP, which is absolutely free

of gaps and has the best possible mechanical properties. The "Off-Peak" property (shock absorption)

cushions the load transfer to the implant. The abutment is also suitable for immediate loading. The

white colour ensures that no dark shadows show through the gingiva. Opaques are therefore not

required any more. The SKY elegance abutments can be veneered directly with visio.lign, or

provided with ceramic or metal crowns and bridges.

In short, the innovative material BioHPP offers new possibilities of fitting patients with fixed and

removable high-value dental prosthetics on implants or natural teeth from individual abutments to

telescoping prosthetics.

The bredent group is an internationally-active, family-run company.

It develops and produces optimally coordinated stand-alone products, system solutions (e.g. in implant

prosthetics) and "Made in Germany" treatment concepts. These enable dentists and dental

technicians to produce and maintain high-quality, cost-effective aesthetic restorations that ensure

periodontal hygiene.


3/3



The bredent group strives to be amongst the best. That is why the employees are always ready to

deliver excellence for our clients and their patients, with the necessary flexibility and openness.

With its expertise and innovative drive, the bredent group is the paradigm for the dental market.

- END -

2,583 characters (without heading and profile)

Press contact

Andreas BischoffMarketing Manager of the bredent group

Telephone +49 (0) 7309/872-396

Fax +49 (0) 7309/872-605

[email protected]

Documents

Latest Press Release Biohpp